Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort.
Clin Res Hepatol Gastroenterol
; 45(1): 101459, 2021 Jan.
Article
in En
| MEDLINE
| ID: mdl-32595103
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Hepatitis C, Chronic
/
Liver Neoplasms
Type of study:
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Res Hepatol Gastroenterol
Year:
2021
Type:
Article